| Improving corrected QT; why individual correction is not enough ND Ether, SR Jantre, DB Sharma, DJ Leishman, MB Bailie, DA Lauver Journal of Pharmacological and Toxicological Methods 113, 107126, 2022 | 9 | 2022 |
| Chimeric mouse model for MRI contrast agent evaluation FF Mir, RP Tomaszewski, DD Shuboni‐Mulligan, CL Mallett, JML Hix, ... Magnetic resonance in medicine 82 (1), 387-394, 2019 | 8 | 2019 |
| QT ratio: A simple solution to individual QT correction ND Ether, DJ Leishman, MB Bailie, DA Lauver Journal of Pharmacological and Toxicological Methods 117, 107211, 2022 | 2 | 2022 |
| Relationship of clinical adverse event reports to models of arrhythmia risk N Ether, D Leishman, M Bailie, A Lauver Journal of pharmacological and toxicological methods 100, 106622, 2019 | 1 | 2019 |
| Which QT Correction Method is Most Consistent? N Ether, M Bailie, D Leishman, A Lauver The FASEB Journal 35, 2021 | | 2021 |
| Evaluating the impact of electrocardiogram analysis methods on the accurate identification of drug-induced changes to QT interval N Ether, DJ Leishman, M Bailie, A Lauver Journal of Pharmacological and Toxicological Methods 105, 2020 | | 2020 |
| Effects of ECG Summarization Methods on the Characterization of Drug‐Induced QT Prolongation–a Demonstration of Need for Standard Methods of ECG Beat Summarization6. 3.6 N Ether, M Bailie, D Leishman, A Lauver The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Improving the prediction of torsade de pointes risk during drug discovery and development N Ether, A Lauver, M Bailie, D Leishman Journal of Pharmacological and Toxicological Methods 99, 106595, 2019 | | 2019 |
| IMPROVING-T CORRECTION METHODS THROUGH THE ANALYSIS OF PRECLINICAL SAFETY PHARMACOLOGY DATA ND Ether | | |
D J LeishmanVice President, Translational and Quantitative Toxicology (TQT)Verified email at safetypharmacologysource.com
